OptimizeRx News

OptimizeRx | 10-Q: Quarterly report

SEC announcementMay 15 16:08 · Announcements

OptimizeRx Price Target Raised to $16.00/Share From $15.00 by JMP Securities

OptimizeRx Price Target Raised to $16.00/Share From $15.00 by JMP Securities

Dow JonesMay 15 12:52

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersSINTX Techs (NASDAQ:SINT) stock moved upwards by 136.2% to $0.13 during Wednesday's regular session. The company's market cap stands at $15.9 million. The company's, Q1 earnings came out 2 days

BenzingaMay 15 11:31

OptimizeRx Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

OptimizeRx Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BenzingaMay 15 10:03

Expert Ratings For OptimizeRx

OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below offers a condensed view of their re

BenzingaMay 15 08:00

OptimizeRx Is Maintained at Buy by Stifel

OptimizeRx Is Maintained at Buy by Stifel

Dow JonesMay 15 07:01

Stifel Maintains Buy on OptimizeRx, Maintains $13 Price Target

Stifel analyst David Grossman maintains OptimizeRx with a Buy and maintains $13 price target.

Analyst UpgradesMay 15 06:51

OptimizeRx Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 13.04% Stifel $13 → $13 Maintains Buy 04/16/2024 30.43% JMP Securities → $15 Reiterates Market

BenzingaMay 15 06:51

Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)

TipRanksMay 15 05:56

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), PepGen Inc. (PEPG) and RegenXBio (RGNX)

TipRanksMay 15 05:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX), Immunocore Holdings (IMCR) and Acadia Healthcare (ACHC)

TipRanksMay 15 04:31

Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2024 Earnings Conference

The following is a summary of the OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript:Financial Performance:OptimizeRx reported Q1 2024 revenues of $19.7 million, a 51% increase year-over-y

Futu NewsMay 15 03:01 · Conference Call

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and OptimizeRx (OPRX)

TipRanksMay 14 23:30

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

OptimizeRx Corporation (OPRX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 14 22:21

OptimizeRx Reiterating Its 2024 Guidance >OPRX

OptimizeRx Reiterating Its 2024 Guidance >OPRX

Dow JonesMay 14 15:22

OptimizeRx Expects FY24 Rev to Be at Least $100 M With Adj EBITDA of at Least $11 M

OptimizeRx Expects FY24 Rev to Be at Least $100 M With Adj EBITDA of at Least $11 M

Dow JonesMay 14 15:22

OptimizeRx Q1 Adj $(0.11) Beats $(0.13) Estimate, Sales $19.69M Beat $18.13M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 22.22 percent decrease over losses of $(0.09) p

BenzingaMay 14 15:12

Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q1 Revenue $19.7M, Vs. Street Est of $18.1M

04:04 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q1 Revenue $19.7M, vs. Street Est of $18.1M

MT NewswiresMay 14 15:04

OptimizeRx 1Q Loss/Shr 38c >OPRX

OptimizeRx 1Q Loss/Shr 38c >OPRX

Dow JonesMay 14 15:01

Press Release: OptimizeRx Reports First Quarter 2024 Financial Results

OptimizeRx Reports First Quarter 2024 Financial Results -- Q1 revenue of $19.7 million, increasing 51% year-over-year -- Q1 gross profit increased 64% year-over-year to $12.2 million with a

Dow JonesMay 14 15:01